Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for treatment of keloid scars
IRCT2016020926489N1Phase 3Completed
- Sponsor
- Faculty of Medicine, Tehran University of Medical Sciences
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in keloid, sponsored by Faculty of Medicine, Tehran University of Medical Sciences. Started Jun 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
keloid
Beyond the preview
Go deeper on IRCT2016020926489N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016020926489N1.